Cite
HARVARD Citation
Ellwanger, K. et al. (n.d.). EGFRvIII TandAbs are specific and highly potent drug candidates for the treatment of solid tumors. Journal for immunotherapy of cancer. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ellwanger, K. et al. (n.d.). EGFRvIII TandAbs are specific and highly potent drug candidates for the treatment of solid tumors. Journal for immunotherapy of cancer. p. . [Online].